Matthew Derrick to Humans
This is a "connection" page, showing publications Matthew Derrick has written about Humans.
Connection Strength
0.103
-
Intrauterine fetal demise can be remote from the inciting insult in an animal model of hypoxia-ischemia. Pediatr Res. 2012 Aug; 72(2):154-60.
Score: 0.012
-
Model of cerebral palsy in the perinatal rabbit. J Child Neurol. 2005 Dec; 20(12):972-9.
Score: 0.008
-
A Survey of Minimally Invasive Surfactant Use in the United States. Am J Perinatol. 2025 Jun; 42(8):1043-1050.
Score: 0.007
-
Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy? J Neurosci. 2004 Jan 07; 24(1):24-34.
Score: 0.007
-
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial. JAMA. 2023 09 19; 330(11):1054-1063.
Score: 0.007
-
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial. JAMA. 2021 12 28; 326(24):2478-2487.
Score: 0.006
-
Effect of Antibiotic Use Within First 48 Hours of Life on the Preterm Infant Microbiome: A Randomized Clinical Trial. JAMA Pediatr. 2021 03 01; 175(3):303-305.
Score: 0.006
-
Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trial. J Pediatr. 2021 02; 229:283-288.e2.
Score: 0.005
-
Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial. J Pediatr. 2019 10; 213:222-226.e2.
Score: 0.005
-
Evaluating the Use of a Decision Aid for Parents Facing Extremely Premature Delivery: A Randomized Trial. J Pediatr. 2019 06; 209:52-60.e1.
Score: 0.005
-
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol. 2019 05; 39(5):599-607.
Score: 0.005
-
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr. 2019 02; 205:41-48.e6.
Score: 0.005
-
Human Umbilical Cord Blood Cells Ameliorate Motor Deficits in Rabbits in a Cerebral Palsy Model. Dev Neurosci. 2015; 37(4-5):349-62.
Score: 0.004
-
A Critical Review of Models of Perinatal Infection. Dev Neurosci. 2015; 37(4-5):289-304.
Score: 0.004
-
Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol. 2012 May; 71(5):589-600.
Score: 0.003
-
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr. 2012 Apr; 160(4):544-552.e4.
Score: 0.003
-
Neuronal nitric oxide synthase inhibition prevents cerebral palsy following hypoxia-ischemia in fetal rabbits: comparison between JI-8 and 7-nitroindazole. Dev Neurosci. 2011; 33(3-4):312-9.
Score: 0.003
-
Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia. J Cereb Blood Flow Metab. 2010 May; 30(5):1053-65.
Score: 0.003
-
Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brain. Ann Neurol. 2009 Sep; 66(3):323-31.
Score: 0.002
-
Fetal brain magnetic resonance imaging response acutely to hypoxia-ischemia predicts postnatal outcome. Ann Neurol. 2007 Apr; 61(4):307-14.
Score: 0.002
-
Serial diffusion tensor imaging detects white matter changes that correlate with motor outcome in premature infants. Dev Neurosci. 2007; 29(4-5):289-301.
Score: 0.002
-
Relation of maternal ethnicity to infant birthweight in east London, England. Ethn Dis. 1997; 7(1):1-4.
Score: 0.001